Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs
Open Access
- 1 February 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (6) , 3406-3410
- https://doi.org/10.1074/jbc.272.6.3406
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha.Proceedings of the National Academy of Sciences, 1995
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Induction of Peroxisomal β-Oxidation by Nonsteroidal Anti-inflammatory DrugsToxicology and Applied Pharmacology, 1993
- Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cellsJournal of Cellular Physiology, 1991
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Preadipocyte differentiation in vitro: Identification of a highly active adipogenic agentJournal of Cellular Physiology, 1988
- Regulation of 3T3-L1 fibroblast differentiation by prostacyclin (prostaglandin I2)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Differentiation of ob 17 preadipocytes to adipocytes triggering effects of clofenapate and indomethacinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- The biosynthesis and possible function of prostaglandins in adipose tissueBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970